Target Name: LOC105375928
NCBI ID: G105375928
Review Report on LOC105375928 Target / Biomarker Content of Review Report on LOC105375928 Target / Biomarker
LOC105375928
Other Name(s): LOC105375928 variant X2 | Uncharacterized LOC105375928, transcript variant X2

LOC105375928: A Potential Drug Target for Cancer

LOC105375928 (LOC105375928 variant X2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the T-cell antigen 6 (TCA6) family, which is a group of cytokines that play a critical role in the immune system.

LOC105375928 variant X2 is a variant of the human T-cell antigen 6 (TCA6) gene. The most common variant of TCA6 is known as TCA6-loc105375928 (LOC105375928), which is a missense mutation that results in the substitution of a single nucleotide at position 28 of the TCA6 gene. This mutation has been shown to have a severe impact on the function of TCA6, leading to a variety of cellular and physiological consequences.

The TCA6 gene encodes a protein that is involved in the development and maintenance of the immune system. TCA6 is a key regulator of the activation and proliferation of T cells, which are a crucial part of the immune system. TCA6 is also involved in the regulation of cell death and in the development of cancer.

The LOC105375928 variant has been shown to have a variety of different effects on the function of TCA6. One of the most significant effects is its ability to disrupt the normal function of TCA6. Studies have shown that LOC105375928-deficient T cells are less able to recognize and respond to antigens, and are more likely to undergo apoptosis. This is thought to result from the fact that LOC105375928-deficient TCA6-positive cells are unable to maintain the expression of TCA6, which is necessary for the survival and proliferation of these cells.

Another interesting property of LOC105375928 is its ability to interact with other proteins. Studies have shown that LOC105375928 can form a complex with the protein PD-L1, which is a negative regulator of TCA6. This complex is thought to play a role in the regulation of TCA6-mediated signaling pathways, which are important for the development and maintenance of the immune system.

LOC105375928 has also been shown to be involved in a variety of cellular processes, including cell adhesion, migration, and invasion. These properties are important for the development of cancer, as cancer cells are able to invade and metastasize to other tissues. LOC105375928 may be a drug target or biomarker for cancer, as its disruption may have implications for the treatment of this disease.

In conclusion, LOC105375928 (LOC105375928 variant X2) is a protein that is involved in the development and maintenance of the immune system. The LOC105375928 variant has a variety of different effects on the function of TCA6, including its ability to disrupt the normal function of TCA6-positive cells and its ability to form a complex with PD-L1. These properties make LOC105375928 a potential drug target or biomarker for cancer. Further research is needed to fully understand the implications of LOC105375928 for the development and treatment of cancer.

Protein Name: Uncharacterized LOC105375928, Transcript Variant X2

The "LOC105375928 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375928 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818